Reports
Sale
United States Generic Drug Market Size, Share, Forecast: By Type: Unbranded, Branded; By Therapy Area: CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, Others; By Drug Delivery; By Distribution Channel; Market Dynamics; Competitive Landscape; 2024-2032
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
7 Opportunities and Challenges in the Market
8 Global Generic Drug Market Overview
8.1 Key Industry Highlights
8.2 Global Generic Drug Historical Market (2018-2023)
8.3 Global Generic Drug Market Forecast (2024-2032)
8.4 Global Generic Drug Market by Region
8.4.1 North America
8.4.2 Europe
8.4.3 Asia Pacific
8.4.4 Latin America
8.4.5 Latin America
9 United States Pharmaceuticals Market Overview
9.1 Key Industry Highlights
9.2 United States Generic Drug Historical Market (2018-2023)
9.3 United States Generic Drug Market Forecast (2024-2032)
9.4 United States Generic Drug Market by Type
10 United States Generic Drug Market Analysis
10.1 Key Industry Highlights
10.2 United States Generic Drug Historical Market (2018-2023)
10.3 United States Generic Drug Market Forecast (2024-2032)
10.4 United States Generic Drug Market by Type
10.4.1 Unbranded
10.4.1.1 Historical Trend (2018-2023)
10.4.1.2 Forecast Trend (2024-2032)
10.4.2 Branded
10.4.2.1 Historical Trend (2018-2023)
10.4.2.2 Forecast Trend (2024-2032)
10.5 United States Generic Drug Market by Therapy Area
10.5.1 CNS
10.5.1.1 Historical Trend (2018-2023)
10.5.1.2 Forecast Trend (2024-2032)
10.5.2 Cardiovascular
10.5.2.1 Historical Trend (2018-2023)
10.5.2.2 Forecast Trend (2024-2032)
10.5.3 Dermatology
10.5.3.1 Historical Trend (2018-2023)
10.5.3.2 Forecast Trend (2024-2032)
10.5.4 Genitourinary/Hormonal
10.5.4.1 Historical Trend (2018-2023)
10.5.4.2 Forecast Trend (2024-2032)
10.5.5 Respiratory
10.5.5.1 Historical Trend (2018-2023)
10.5.5.2 Forecast Trend (2024-2032)
10.5.6 Rheumatology
10.5.6.1 Historical Trend (2018-2023)
10.5.6.2 Forecast Trend (2024-2032)
10.5.7 Diabetes
10.5.7.1 Historical Trend (2018-2023)
10.5.7.2 Forecast Trend (2024-2032)
10.5.8 Oncology
10.5.8.1 Historical Trend (2018-2023)
10.5.8.2 Forecast Trend (2024-2032)
10.5.9 Others
10.6 United States Generic Drug Market by Drug Delivery
10.6.1 Oral
10.6.1.1 Historical Trend (2018-2023)
10.6.1.2 Forecast Trend (2024-2032)
10.6.2 Injectables
10.6.2.1 Historical Trend (2018-2023)
10.6.2.2 Forecast Trend (2024-2032)
10.6.3 Dermal/Topical
10.6.3.1 Historical Trend (2018-2023)
10.6.3.2 Forecast Trend (2024-2032)
10.6.4 Inhalers
10.6.4.1 Historical Trend (2018-2023)
10.6.4.2 Forecast Trend (2024-2032)
10.6.5 Others
10.7 United States Generic Drug Market by Distribution Channel
10.7.1 Retail Pharmacies
10.7.1.1 Historical Trend (2018-2023)
10.7.1.2 Forecast Trend (2024-2032)
10.7.2 Hospital Pharmacies
10.7.2.1 Historical Trend (2018-2023)
10.7.2.2 Forecast Trend (2024-2032)
11 Market Dynamics
11.1 SWOT Analysis
11.1.1 Strengths
11.1.2 Weaknesses
11.1.3 Opportunities
11.1.4 Threats
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyers Power
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 Key Indicators for Demand
11.4 Key Indicators for Price
12 Value Chain Analysis
13 Regulations in the US Generic Drug Industry
13.1 Overview of Pharmaceutical Regulations
13.2 Drug Applications
13.3 Patents and Market Exclusivity
13.4 Regulatory Requirements for Generic Drugs
13.5 The Hatch-Waxman Act
13.6 Certifications
13.7 Other Important Considerations
14 Requirements for Setting Up a Generic Drug Manufacturing Plant
14.1 Manufacturing Process
14.2 Raw Material Requirements
14.3 Land and Construction Requirements
14.4 Machinery and Infrastructure Requirements
14.5 Machinery Pictures
14.6 Plant Layout
14.7 Packaging Requirements
14.8 Utility Requirements
14.9 Manpower Requirements
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Teva Pharmaceuticals USA, Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Financial Summary
15.2.1.5 Certifications
15.2.2 Sandoz Inc.
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Financial Summary
15.2.2.5 Certifications
15.2.3 Sun Pharmaceutical Industries Ltd.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Financial Summary
15.2.3.5 Certifications
15.2.4 Lupin Pharmaceuticals, Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Financial Summary
15.2.4.5 Certifications
15.2.5 Par Pharmaceutical
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Financial Summary
15.2.5.5 Certifications
15.2.6 Endo Pharmaceuticals
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Financial Summary
15.2.6.5 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Generic Drug Market: Key Industry Highlights, 2018 and 2032
2. United States Pharmaceutical Market: Key Industry Highlights, 2018 and 2032
3. United States Generic Drug Market: Key Industry Highlights, 2018 and 2032
4. United States Generic Drug Historical Market: Breakup by Type (USD Billion), 2018-2023
5. United States Generic Drug Market Forecast: Breakup by Type (USD Billion), 2024-2032
6. United States Generic Drug Historical Market: Breakup by Therapy Area (USD Billion), 2018-2023
7. United States Generic Drug Market Forecast: Breakup by Therapy Area (USD Billion), 2024-2032
8. United States Generic Drug Historical Market: Breakup by Drug Delivery (USD Billion), 2018-2023
9. United States Generic Drug Market Forecast: Breakup by Drug Delivery (USD Billion), 2024-2032
10. United States Generic Drug Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
11. United States Generic Drug Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
12. United States Generic Drug Market Structure
Key Questions Answered in the Report
In 2023, the United States generic drug market attained a value of nearly USD 163.68 billion.
The market is projected to grow at a CAGR of 12% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 453.98 billion by 2032.
The major drivers of the market are rising disposable incomes, increasing population, rising incidences of chronic diseases, and growing technological advancements.
The key trends guiding the growth of the market include the launch of several programs to promote generic substitution in the country and increasing hygiene awareness.
The major types in the market include unbranded and branded generic drugs.
The major therapy areas in the market include CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, and oncology, among others.
The different modes of drug delivery are injectables, dermal/topical, inhalers, and oral drugs, among others.
The major distribution channels in the market are hospital pharmacies and retail pharmacies.
The major players in the United States generic drug market are Teva Pharmaceuticals USA, Inc., Sandoz Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Par Pharmaceutical, and Endo Pharmaceuticals, among others.
Analyst Review
The United States generic drug market attained a value of USD 163.68 billion in 2023 driven by rise in the incidences of chronic diseases. Aided by technological advancements, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 12%. The United States generic drug market is projected to reach USD 453.98 billion by 2032.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its type, the United States market can be categorised into unbranded and branded generic drugs. On the basis of therapy areas, the industry is divided into CNS, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, oncology, and others. On the basis of drug delivery, oral drugs are leading the market. On the basis of distribution channels, the hospital pharmacies sector accounts for the leading share in the industry. The key players in the above market include Teva Pharmaceuticals USA, Inc., Sandoz Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Par Pharmaceutical, Endo Pharmaceuticals, and others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER